The Systemic Immune-Inflammation Index is an Independent Predictor of Survival in Breast Cancer Patients.

Mengliu ZhuLi ChenXiangyi KongXiangyu WangXingrui LiYi Fang Jing Wang

Published in: Cancer management and research (2022)

SII can be used as an easily accessible and minimally invasive potential prognostic factor in individuals with breast cancer and may also guide clinicians in treating and prognosticating patients with breast cancer.

Keyphrases

prognostic factors
minimally invasive
oxidative stress
palliative care
robot assisted
human health
free survival
risk assessment
young adults
climate change
childhood cancer